Literature DB >> 20882990

Identification of the amyloid β-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics.

Can-E Tang1, Yong-Jun Guan, Bin Yi, Xin-Hui Li, Ke Liang, Hai-Yan Zou, Hong Yi, Mao-Yu Li, Peng-Fei Zhang, Cui Li, Fang Peng, Zhu-Chu Chen, Kai-Tai Yao, Zhi-Qiang Xiao.   

Abstract

The epidermal growth factor receptor (EGFR) is usually overexpressed in nasopharyngeal carcinoma (NPC) and is associated with pathogenesis of NPC. However, while EGFR-modulated intracellular proteins have been extensively studied, little is known concerning their extracellular counterparts. To identify EGFR-regulated secreted proteins in NPC, we compared the secretome profiles of TGF-α-stimulated and unstimulated NPC cell line CNE-2. CNE-2 cells were cultured in the absence or presence of TGF-α for 24 h, and secreted proteins were obtained from conditioned serum-free media and enriched by ultrafiltration centrifugation. Using 2-DE and subsequent mass spectrometry, we identified 16 differential secreted proteins, among which the amyloid β-protein precursor (APP) was up-regulated and cystatin C was down-regulated after TGF-α stimulation. We further showed that the secretory changes of APP and cystatin C in CNE-2 after TGF-α stimulation could be abrogated by pretreatment of EGFR tyrosine kinase inhibitor PD153035 and PI3 kinase inhibitor Wortmannin, validating that APP and cystatin C are EGFR-regulated secreted proteins in NPC cells. Immunohistochemistry showed that the expression level of EGFR was positively correlated with the expression level of APP and negatively correlated with the expression level of cystatin C in NPC tissues, indicating that EGFR also regulates expression of APP and cystatin C in clinical NPC tissues. Furthermore, functional analysis showed that the growth and migration of CNE-2 cells decreased after neutralization of secretory APP in the medium using the anti-APP antibody. Our data provide substantial evidence that APP and cystatin C are target secreted proteins of EGFR in NPC, and upregulation of secretory APP by EGFR may be involved in the pathogenesis of NPC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20882990     DOI: 10.1021/pr100663p

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  14 in total

1.  Global secretome analysis identifies novel mediators of bone metastasis.

Authors:  Mario Andres Blanco; Gary LeRoy; Zia Khan; Maša Alečković; Barry M Zee; Benjamin A Garcia; Yibin Kang
Journal:  Cell Res       Date:  2012-06-12       Impact factor: 25.617

2.  Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblasts.

Authors:  Shenglei Ge; Yitao Mao; Yan Yi; Dinghua Xie; Zhuchu Chen; Zhiqiang Xiao
Journal:  Exp Ther Med       Date:  2012-02-13       Impact factor: 2.447

Review 3.  Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.

Authors:  Danielle L Chappell; Maria C White; Blossom Damania
Journal:  Adv Virus Res       Date:  2020-11-09       Impact factor: 9.937

Review 4.  A Review: Proteomics in Nasopharyngeal Carcinoma.

Authors:  Ze-Tan Chen; Zhong-Guo Liang; Xiao-Dong Zhu
Journal:  Int J Mol Sci       Date:  2015-07-08       Impact factor: 5.923

5.  Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma.

Authors:  Jin-Zhang Cheng; Jun-Jun Chen; Kai Xue; Zong-Gui Wang; Dan Yu
Journal:  Cancer Cell Int       Date:  2018-08-13       Impact factor: 5.722

6.  Amyloid β precursor protein silencing attenuates epithelial‑mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway.

Authors:  Jin Xu; Yin Ying; Gaoyun Xiong; Liqin Lai; Qingliang Wang; Yue Yang
Journal:  Mol Med Rep       Date:  2019-05-24       Impact factor: 2.952

7.  A novel role of HuR in -Epigallocatechin-3-gallate (EGCG) induces tumour cells apoptosis.

Authors:  Wenxuan Jian; Shuhuan Fang; Tongkai Chen; Jiansong Fang; Yousheng Mo; Dongli Li; Sha Xiong; Wei Liu; Lei Song; Jiangang Shen; Yong Xia; Qi Wang; Honghai Hong
Journal:  J Cell Mol Med       Date:  2019-02-22       Impact factor: 5.310

8.  Clinical significance of amyloid precursor protein in patients with testicular germ cell tumor.

Authors:  Yuta Yamada; Tetsuya Fujimura; Satoru Takahashi; Kenichi Takayama; Tomohiko Urano; Taro Murata; Daisuke Obinata; Yasuyoshi Ouchi; Yukio Homma; Satoshi Inoue
Journal:  Adv Urol       Date:  2013-04-14

Review 9.  Amyloid precursor protein and amyloid precursor-like protein 2 in cancer.

Authors:  Poomy Pandey; Bailee Sliker; Haley L Peters; Amit Tuli; Jonathan Herskovitz; Kaitlin Smits; Abhilasha Purohit; Rakesh K Singh; Jixin Dong; Surinder K Batra; Donald W Coulter; Joyce C Solheim
Journal:  Oncotarget       Date:  2016-04-12

10.  High sensitivity of gold nanoparticles co-doped with Gd2O3 mesoporous silica nanocomposite to nasopharyngeal carcinoma cells.

Authors:  Hui Wang; Songjin Zhang; Xiumei Tian; Chufeng Liu; Lei Zhang; Wenyong Hu; Yuanzhi Shao; Li Li
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.